> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-239/
- Published: 2019-09-22T12:00:00.000Z
- Updated: 2026-09-15T01:51:28.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145067

[**Comments Sought on Developing CNS Stimulants**](https://www.fdaweb.com/comments-sought-on-developing-cns-stimulants/)  
*Federal Register* notice: FDA seeks comments on development and evaluation of abuse-deterrent formulations of central nervous system stimulants. 09/20/2019

[**Device Guidances Under Safety/Performance Pathway**](https://www.fdaweb.com/device-guidances-under-safety-performance-pathway/)  
*Federal Register* notice: FDA makes available several device-specific draft guidance documents for the agency’ device Safety and Performance Based Pathway. 09/20/2019

[**Info Collection Extension on MedSun Reporting**](https://www.fdaweb.com/info-collection-extension-on-medsun-reporting-2/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for it MedSun adverse event program for medical devices. 09/19/2019

[**Guide on Safer Technologies Device Program** ](https://www.fdaweb.com/guide-on-safer-technologies-device-program/)*Federal Register* notice: FDA posts a draft guidance entitled “Safer Technologies Program for Medical Devices,” a new, voluntary program for certain devices and combination products that offer safer options than currently marketed products. 09/19/2019

[**Final Guide on 505(q) Citizen Petitions**](https://www.fdaweb.com/final-guide-on-505-q-citizen-petitions/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act.” 09/19/2019

[**Info Collection Extension for Post-market Studies**](https://www.fdaweb.com/info-collection-extension-for-post-market-studies/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for drug/biologic postmarketing studies status reports. 09/18/2019

[**Emergency Use Revoked for Luminex Zika Assay**](https://www.fdaweb.com/emergency-use-revoked-for-luminex-zika-assay/)  
*Federal Register* notice: FDA revokes an emergency use authorization issued to Luminex for the xMAP MultiFLEX Zika RNA Assay. 09/18/2019

[**53 Product-Specific Guidances for ANDAs**](https://www.fdaweb.com/53-product-specific-guidances-for-andas/)  
*Federal Register* notice: FDA makes available 53 product-specific guidances (PSGs) – 34 new guidances and 19 revised ones. 09/17/2019

[**FDA Revokes Zika Test Emergency Authorization**](https://www.fdaweb.com/fda-revokes-zika-test-emergency-authorization/)  
*Federal Register* notice: FDA revokes an Emergency Use Authorization issued to Siemens Healthcare Diagnostics for the Advia Centaur Zika test. 09/16/2019